The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

Ambev Reports 2012 Third Quarter Results Under IFRS

Wednesday, October 31, 2012

Ambev Reports 2012 Third Quarter Results Under IFRS02:34 EDT Wednesday, October 31, 2012SAO PAULO, Oct. 31, 2012 /PRNewswire/ -- Companhia de Bebidas das Americas ? Ambev [BOVESPA: AMBV4, AMBV3; NYSE: ABV, ABVc] announces today its results for the 2012 third quarter (Q3 2012). The following operating and financial information, unless otherwise indicated, is presented in nominal Reais and prepared according to International Financial and Reporting Standards (IFRS), and should be read together with our quarterly financial information for the three and nine months period ended September 30, 2012 filed with the CVM and submitted to the SEC.Operating and Financial HighlightsTop line performance: This quarter we delivered the strongest net revenue growth (+15.1%) of the year despite a 0.5% decline in overall volumes (+0.3% in beer; -2.3% in CSD&NANC), giving us +2.1% volume and +9.3% net revenue per hectoliter (NR/Hl) growth for the year.  The performance of our Brazilian operations stood out once more, with a 17.5% NR/Hl growth while volume growth was limited to 0.2%.  As for our international operations, Canadian performance was flat, Latin America South (LAS) NR/Hl growth of 21.5% more than offset a 2.3% decline in volumes against a tough macroeconomic backdrop in Argentina, and HILA-ex reported volumes that grew roughly 55% in the first full quarter of consolidation of Cervecería Nacional Dominicana's (CND) results.     Cost of Goods Sold (COGS): COGS rose 11% in the third quarter, with COGS per hectoliter growing 11.3%.  This was primarily caused by input cost pressures in Brazil for barley, aluminum and sugar, coupled with negative packaging mix and greater industrial depreciation related to capacity investments in the country, but also due to higher barley and labor costs in LAS.  For the first nine months of 2012, COGS/Hl increased 6.6%.Selling, General & Administrative (SG&A) expenses: SG&A (excluding depreciation and amortization) expenses in Q3 2012 grew 16.2%.  Commercial spend and distribution expenses increased at a lower pace as compared to H1 2012 (with the exception of LAS, where labor cost pressures persist), whereas growth in administrative expenses in Brazil (mainly bonus accruals) mostly resulted from a tough comparison with Q3 2011.  Year-to-date, SG&A (excluding depreciation and amortization) growth stands at 15.1%.EBITDA, Gross margin and EBITDA margin: We delivered a normalized EBITDA of R$ 3,801.5 million in the third quarter, which is 19.2% above the same period last year, giving us 12.5% growth thru September 30, 2012.  Both Gross and EBITDA margins expanded (120 bps and 160 bps, respectively) led by Brazil and LAS, while Canadian EBITDA margin remained flat for the quarter, and HILA-ex improved its EBITDA margin considerably to 16.7%, with an EBITDA of R$ 66.8 million.  These results sent us back to margin expansion territory for the year (+30 bps), with an EBITDA margin of 46.0%.Operating Cash generation and Profit: Stronger revenue performance was the main driver behind the R$ 4,365.6 million (+27.6% vs. Q3 2011) of cash generated from our operations during Q3 2012.  Normalized Profit was R$ 2,518.5 million and Normalized Earnings per share (EPS) was R$ 0.81 in the quarter thanks to a higher EBITDA, a lower effective tax rate and an easy comparison with Q3 2011. Financial Highlights ? Ambev Consolidated % As%% As%R$ million3Q113Q12ReportedOrganicYTD 11YTD 12ReportedOrganicTotal volumes39,920.240,530.21.5%-0.5%116,898.4120,139.12.8%2.1%Beer28,607.029,371.72.7%0.3%84,176.186,487.82.7%1.9%CSD and NANC11,313.111,158.4-1.4%-2.3%32,722.333,651.32.8%2.4%Net sales6,374.58,036.026.1%15.1%18,748.322,097.117.9%11.7%Gross profit4,244.35,414.127.6%17.1%12,492.314,862.119.0%13.1%Gross margin66.6%67.4%80 bps120 bps66.6%67.3%70 bps80 bpsEBITDA2,994.73,791.826.6%17.5%8,671.510,131.016.8%11.8%EBITDA margin47.0%47.2%20 bps100 bps46.3%45.8%-50 bps10 bpsNormalized EBITDA2,952.83,801.528.7%19.2%8,634.910,167.417.7%12.5%Normalized EBITDA margin46.3%47.3%100 bps160 bps46.1%46.0%-10 bps30 bpsProfit - Ambev holders1,687.32,508.848.7%5,608.56,787.721.0%Normalized Profit - Ambev holders1,645.42,518.553.1%5,571.96,824.122.5%No. of share outstanding (millions)3,116.83,126.23,116.83,126.2EPS (R$/shares)0.540.8048.2%1.802.1720.7%Normalized EPS0.530.8152.6%1.792.1822.1%Note: Earnings per share calculation is based on outstanding shares (total existing shares excluding shares held in treasury).This press release segregates the impact of organic changes from those arising from changes in scope or currency translation. Scope changes represent the impact of acquisitions and divestitures, the start up or termination of activities or the transfer of activities between segments, curtailment gains and losses and year over year changes in accounting estimates and other assumptions that management does not consider as part of the underlying performance of the business. Unless stated, percentage changes in this press release are both organic and normalized in nature. Whenever used in this document, the term "normalized" refers to performance measures (EBITDA, EBIT, Profit, EPS) before special item adjustments. Special items are either income or expenses which do not occur regularly as part of the normal activities of the Company. They are presented separately because they are important for the understanding of the underlying sustainable performance of the Company due to their size or nature. Normalized measures are additional measures used by management and should not replace the measures determined in accordance with IFRS as indicators of the Company's performance. Comparisons, unless otherwise stated, refer to the third quarter of 2011 (Q3 2011), as the case may be. Values in this release may not add up due to roundingSOURCE AmbevFor further information: Tatiana S F Rodrigues, Ambev - Investor Relations, + 55 (11) 2122-1414, ir@ambev.com.br